(Q44237130)

1 December 2017

No effect of rosuvastatin on the pharmacokinetics of digoxin in healthy volunteers (English)

1 reference

1 December 2017

0 references

1 reference

Paul D Martin

1

1 reference

1 December 2017

John Kemp

2

1 reference

1 December 2017

Aaron L Dane

3

1 reference

1 December 2017

Mike J Warwick

4

1 reference

1 December 2017

Dennis W Schneck

5

1 reference

1 December 2017

1 December 2002

1 reference

The Journal of Clinical Pharmacology

1 December 2017

1 reference

1 December 2017

42

1 reference

1 December 2017

12

1 reference

1 December 2017

1352-1357

1 reference

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

1 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270002042012008

Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002042012008

Pharmacokinetic effects of fluvastatin in patients chronically receiving digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002042012008

Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002042012008

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002042012008

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002042012008

Clinical pharmacokinetics of fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002042012008

10.1177/0091270002042012008

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference